These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15657730)

  • 41. Combination of pulse therapy with terbinafine tablets and topical terbinafine cream for the treatment of dermatophyte onychomycosis: a pilot study.
    Nakano N; Hiruma M; Shiraki Y; Chen X; Porgpermdee S; Ikeda S
    J Dermatol; 2006 Nov; 33(11):753-8. PubMed ID: 17073989
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Severe skin rash in patients treated with terbinafine].
    Danielsen AG; Thomsen JS; Svejgaard EL
    Ugeskr Laeger; 2006 Oct; 168(44):3825-6. PubMed ID: 17118244
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Terbinafine (Lamisil)].
    Breton MC
    Union Med Can; 1995 Nov; 124(3):20-5. PubMed ID: 8560634
    [No Abstract]   [Full Text] [Related]  

  • 44. Terbinafine exacerbates psoriasis: case report with a literature review.
    Szepietowski JC
    Acta Dermatovenerol Croat; 2003; 11(1):17-21. PubMed ID: 12718791
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Terbinafine-induced persistent agueusia: first reported case].
    Schmutz JL; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 2000 Mar; 127(3):341. PubMed ID: 10804319
    [No Abstract]   [Full Text] [Related]  

  • 46. Interaction between terbinafine and warfarin.
    Gupta AK; Ross GS
    Dermatology; 1998; 196(2):266-7. PubMed ID: 9568423
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extensive cutaneous hyperpigmentation caused by minocycline.
    Pepine M; Flowers FP; Ramos-Caro FA
    J Am Acad Dermatol; 1993 Feb; 28(2 Pt 2):292-5. PubMed ID: 8436641
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Keep an eye on the side effects].
    Wirtz M; Helbig D
    Hautarzt; 2014 Oct; 65(10):856-9. PubMed ID: 25228031
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection.
    Paredes AH; Lewis JH
    Ann Pharmacother; 2007 May; 41(5):880-4. PubMed ID: 17426078
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Study on the compliance and safety of the oral antifungal agents for the treatment of onychomycosis].
    Hu Y; Yang LJ; Wei L; Dai XY; Hua HK; Qi J; Sun H; Zheng Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Dec; 26(12):988-91. PubMed ID: 16676597
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Subacute cutaneous lupus erythematosus induced by terbinafine].
    Amitay-Layish I; Feuerman H; David M
    Harefuah; 2006 Jul; 145(7):480-2, 552. PubMed ID: 16900733
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Terbinafine. An update of its use in superficial mycoses.
    McClellan KJ; Wiseman LR; Markham A
    Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Generalized pustular psoriasis and hepatic dysfunction associated with oral terbinafine therapy.
    Kim BS; Jang HS; Jwa SW; Jang BS; Kim MB; Oh CK; Kwon YW; Kwon KS
    J Korean Med Sci; 2007 Feb; 22(1):167-9. PubMed ID: 17297275
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Acute hepatitis related to the ingestion of terbinafine].
    Vantaux P; Grasset D; Nougue J; Lagier E; Seigneuric C
    Gastroenterol Clin Biol; 1996; 20(4):402-3. PubMed ID: 8758509
    [No Abstract]   [Full Text] [Related]  

  • 55. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK; Gregurek-Novak T
    Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trichophyton rubrum DNA strain switching increases in patients with onychomycosis failing antifungal treatments.
    Gupta AK; Nakrieko KA
    Br J Dermatol; 2015 Jan; 172(1):74-80. PubMed ID: 24903451
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Diffuse grey-black hyperpigmentation of facial skin in a 59-year-old woman].
    Nenoff P; Müller H; Schulze I; Laumanns A; Handrick W
    Hautarzt; 2015 Mar; 66(3):214-7. PubMed ID: 25636801
    [No Abstract]   [Full Text] [Related]  

  • 58. Combination therapy consisting of week pulses of oral terbinafine plus topical application of terbinafine cream in the treatment of onychomycosis.
    Sanmano B; Hiruma M; Mizoguchi M; Ogawa H
    J Dermatolog Treat; 2004 Jul; 15(4):245-51. PubMed ID: 15764040
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Cutaneous lupus erythematosus induced by terbinafine].
    Møller M; Bygum A
    Ugeskr Laeger; 2006 Dec; 168(50):4427-8. PubMed ID: 17217873
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks.
    Filho ST; Cucé LC; Foss NT; Marques SA; Santamaria JR
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):141-6. PubMed ID: 9784040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.